United States· US:60505-6289_8caba6b7-91fa-e7fb-9e6b-5e83a25ac4ad

eribulin mesylate

A eribulin product containing eribulin mesylate, registered in United States by Apotex Corp.. The same ATC class is registered in 18 of our 19 countries.

ATC L01XX41

Checked against FDA National Drug Code directory (United States) on September 27, 2026

Informational only — not a medical device.

Compare price across countriesPer daily dose · free account Ask the assistant about eribulin mesylateAnswers with sources · free account Check interactionsSeverity free · mechanism on Growth

Where it is registered

Eribulin is registered in 18 of 19 countries.

Countries holding a registration under ATC L01XX41 (eribulin), each read from that country’s own register.

This record: United States, from FDA National Drug Code directory (United States)
10 of them publish a price we can compare per daily dose

Search eribulin products by name

Eribulin · ATC L01XX41

18 / 19 countries

Belgiumprice
Canada
Czechiaprice
Denmark
Finlandprice
Franceprice
Germany
Icelandprice
Ireland
Japan
Netherlands
Norwayprice
Polandprice
Spainprice
Sweden
Switzerlandprice
United Kingdom
United Statesprice

Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

FDA National Drug Code directory (United States)

Active substance: ERIBULIN MESYLATE
Manufacturer: Apotex Corp.
Country: United States (US)
ATC code: L01XX41
ATC class: Eribulin
Defined daily dose: 0.21 mg, P
Reimbursed: Not published by this register
Source register: FDA National Drug Code directory (United States)
Last checked: September 27, 2026

Packs & prices · 1

ndc11
60505-6289-0

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

428 interactions on record for eribulin.

Graded by severity as the source publishes them — 93 severe. Severity grades are free for everyone; mechanism and management come with Growth.

Severity for every pair — free, no plan needed
The source, licence and sync date on every record
Mechanism and what to do for each pair — Growth plan

Check eribulin against other medicines How interaction checks work

Eribulin · interactions on record

428 records

93 severe
331 moderate
4 minor

Most severe, free to view

PapaverineA03AD01severe
CisaprideA03FA02severe
DolasetronA04AA04severe
QuinidineC01BA01severe

Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.

Mechanism and what to do, in the interaction check

Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Eribulin in 16 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All eribulin products

Authorised across Europe · EMA

The same active substance is authorised in 30 EEA countries. Names it is sold under:

Austria · Eribulin Accord, Eribulin Advanz Pharma
Belgium · Eribulin Advanz Pharma, Eribulin Eg
Bulgaria · Eribulin Ever Pharma, Sclarint
Czechia · Erhopana, Eribulin Accord
Germany · Eribulin Aqvida, Eribulin Beta
Denmark · Eribulin Accord, Eribulin Ever Pharma
Estonia · Eribulin, Eribulin Accord
Spain · Eribulina, Eribulina Advanz Pharma
Finland · Eribulin, Eribulin Accord
France · Eribuline Accord, Eribuline Advanz Pharma
United Kingdom (Northern Ireland) · Eribulin Dr. Reddy's Laboratories (Uk), Eribulin Glenmark Pharmaceuticals Europe
Greece · Eribulin Ever Pharma
Croatia · Eribulin, Eribulin Accord
Hungary · Eribulin Advz, Eribulin Ever Pharma
Ireland · Eribulin Advanz Pharma, Eribulin Ever Pharma
Iceland · Advz, Eribulin Advanz Pharma
Italy · Eribulina Advanz Pharma, Eribulina Eg
Liechtenstein · Eribulin Baxter, Halaven
Lithuania · Eribulin, Eribulin Accord
Luxembourg · Eribulin Eg
Latvia · Eribulin, Eribulin Advz
Malta · Eribulin Tillomed
Netherlands · Eribulin Ever Pharma, Eribuline Hikma
Norway · Eribulin Accord, Eribulin Advanz Pharma
Poland · Eribulin Ever Pharma
Portugal · Eribulina Advanz Pharma, Eribulina Cttq
Romania · Erhopana, Eribulin Ever Pharma
Sweden · Eribulin, Eribulin Accord
Slovenia · Eribulin Ever Pharma
Slovakia · Eribulin Advz, Eribulin Agmed

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload

GET /v1/drugs/b82b16c2-f299-4588-adc8-b8049c675dec
GET /v1/drugs/b82b16c2-f299-4588-adc8-b8049c675dec?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "route": "INTRAVENOUS",
  "source": "ndc",
  "strength": ".5",
  "substance": "ERIBULIN MESYLATE",
  "productndc": "60505-6289",
  "dosage_form": "INJECTION",
  "dea_schedule": null,
  "strength_unit": "mg/mL",
  "application_number": "ANDA218047",
  "marketing_category": "ANDA"
}

API reference MCP server Plans

See everything about eribulin.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it free Open in the console